Wound cleansing apparatus
US-9289542-B2 · Mar 22, 2016 · US
US11090409B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11090409-B2 |
| Application number | US-201815982769-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 17, 2018 |
| Priority date | Apr 9, 2010 |
| Publication date | Aug 17, 2021 |
| Grant date | Aug 17, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
According to an illustrative embodiment a method to promote healing of a wound is provided comprising contacting the wound with a biologically active composition comprising a lipoic acid derivative and gelatin. In another embodiment a wound dressing is provided comprising a scaffold coated with a biologically active composition comprising a lipoic acid derivative. In a further embodiment, a system is provided for treating a tissue site of a patient, the system comprising a reduced-pressure source to supply reduced pressure, a manifold to distribute reduced pressure to a tissue site and a scaffold coated with a biologically active composition comprising a lipoic acid derivative. Methods for producing such a system and scaffold are also disclosed.
Opening claim text (preview).
We claim: 1. A reduced-pressure therapy system for treating a tissue site, comprising: a manifold at least partially coated with a composition comprising a gelatin substrate, a lipoic acid derivative, and a chelating agent, wherein the composition reduces excessive matrix metalloprotease activity, and wherein the lipoic acid derivative has the structure: wherein n 1 and n 2 are, independently, C 1 -C 10 alkyl; and R 1 is H, C 1 -C 10 alkyl, C 6 -C 14 aryl, an alkyl ammonium or a protonated amino acid; a drape adapted to provide a sealed space around the manifold and the tissue site; and a reduced-pressure source configured to deliver reduced pressure to the sealed space. 2. The system of claim 1 , further comprising a scaffold adapted to be positioned between the manifold and the tissue site, wherein the scaffold has a plurality of passages. 3. The system of claim 2 , wherein the scaffold comprises polyurethane or collagen. 4. The system of claim 2 , further comprising a release layer adapted to be positioned between the scaffold and the manifold. 5. The system of claim 1 , further comprising an interface for fluidly coupling the reduced-pressure source to the sealed space. 6. The system of claim 1 , wherein the lipoic acid derivative comprises alpha-lipoic acid or sodium lipoate. 7. The system of claim 1 , wherein the chelating agent comprises ethylenediaminetetraacetic acid. 8. The system of claim 1 , wherein the composition further comprises an antimicrobial agent, a growth factor, or a preservative. 9. The system of claim 8 , wherein the antimicrobial agent is non-ionic silver, polyhexamethylene biguanide, chlorhexidine, benzalconium chloride, or triclosan. 10. The system of claim 1 , wherein the composition further preserves granulation tissue. 11. The system of claim 1 , wherein the composition is formulated for time-controlled release of the lipoic acid derivative. 12. The system of claim 1 , wherein the composition comprises 0.1% to 25% w/w gelatin substrate. 13. The system of claim 1 , wherein the composition comprises a bloom value of between about 150-300 g. 14. The system of claim 1 , wherein the composition comprises a bloom value of between about 200-250 g. 15. The system of claim 1 , wherein the composition comprises a bloom value of about 225 g.
with gas or fluid supply means, e.g. for supplying rinsing fluids or anticoagulants (for negative pressure wound therapy A61M1/92, A61M1/94; combined with tracheal tubes A61M16/0463; dental instruments with combined rinsing and aspirating A61C17/0208) · CPC title
with liquid supply means · CPC title
Constructional details of the pressure distribution manifold · CPC title
having five-membered rings · CPC title
Quaternary ammonium compounds, e.g. edrophonium, choline (betaines A61K31/205) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.